Description
Your oncologist may prescribe Zydelig to treat specific blood cancers, notably chronic lymphocytic leukemia (CLL), B-cell non-Hodgkin lymphoma (HL), or relapsed small lymphocytic lymphoma (SLL).
It belongs to the class of drugs called phosphoinositide 3-kinase (PI3K) inhibitors, which target specific enzymes crucial for cancer cell growth and survival. By inhibiting these enzymes, Zydelig aids in slowing disease progression and enhancing patient outcomes.
Fact Table
|
Formula
|
C22H18FN7O
|
License
|
US FDA, EMA
|
Bioavailability
|
N/A (rapidly metabolized to active form)
|
Legal status
|
Prescription only (?)
|
Chemical Name
|
8-[6-(3-hydroxy-1H-indazol-4-yl)quinazolin-2-yl]isoquinolin-1-one
|
Elimination half-life
|
8.2 hours (Idelalisib), 10.5 hours (active metabolite GS-563117)
|
Dosage (Strength)
|
100 mg, 150 mg tablets
|
Pregnancy
|
Not recommended
|
Brands
|
Zydelig
|
Protein binding
|
93% (Idelalisib), 99% (active metabolite GS-563117)
|
PubChem CID
|
11625857
|
MedlinePlus
|
a614029
|
ChEBI
|
CHEBI:85992
|
ATC code
|
L01XX47
|
DrugBank
|
DB08930
|
KEGG
|
D10235
|
Routes of administration
|
Oral
|
Directions
The usual dosage of Zydelig is 150 mg by mouth twice daily. Consult your physician before stopping, starting, or changing the dosage.
Ingredients
The active ingredient in Zydelig is idelalisib.
Interactions
Tell your doctor and pharmacist if you are taking any of the following:
- Alfuzosin
- Alprazolam
- Colchicine
- Conivaptan
- Dihydroergotamine
- Dronedarone
- Eletriptan
- Eliglustat
- Eplerenone
- Ergotamine
- Finerenone
- Gepirone
- Isavuconazonium Sulfate
- Ivabradine
- Lomitapide
- Lovastatin
- Lurasidone
- Maraviroc
- Mavacamten
- Naloxegol
- Pacritinib
- Pimozide
- Ranolazine
- Silodosin
- Simvastatin
- Tolvaptan
- Triazolam
- Ubrogepant
- Venetoclax
- Voclosporin
Cautions
Zydelig may lead to skin reactions; if severe, discontinue usage and promptly inform your healthcare provider.
Regular monitoring of blood cell levels is important when starting this drug and during treatment.
Avoid Zydelig if pregnant, planning pregnancy, or breastfeeding.
Discuss your entire medication list with your pharmacist and doctor due to potential drug interactions.
Tell your doctor about kidney or liver problems before starting Zydelig.
Do not take Zydelig if you have a history of severe hypersensitivities (allergic reactions), including skin reactions.
Side Effects
Common adverse reactions to Zydelig may include:
- Anaphylaxis
- Colitis
- Cough
- Cytomegalovirus infection
- Diarrhea
- Drug reaction with eosinophilia and systemic symptoms (DRESS)
- Erythroderma
- Fatigue
- Febrile neutropenia
- Fever
- Hepatotoxicity, serious or fatal
- Hypersensitivity reaction
- Increased liver enzymes
- Infectious disease
- Nausea
- Neutropenia, All Grades
- Neutropenia, Grade 3 or 4
- Perforation of intestine
- Pneumocystis jirovecii present
- Pneumonia
- Pneumonitis
- Rash
- Sepsis
- Shivering
- Stevens-Johnson syndrome
- Toxic epidermal necrolysis
References
Zydelig [package insert]. Foster City, CA: Gilead; July 2014.
About Dr. Conor Sheehy (Page Author)
Dr. Sheehy (BSc Molecular Biology, PharmD) works a clinical pharmacist specializing in cardiology, oncology, and ambulatory care. He’s a board-certified pharmacotherapy specialist (BCPS), and his experience working one-on-one with patients to fine tune their medication and therapy plans for optimal results makes him a valuable subject matter expert for our pharmacy. Read More....
IMPORTANT NOTE:
The above information is intended to increase awareness of health information and does not suggest treatment or diagnosis. This information is not a substitute for individual medical attention and should not be construed to indicate that use of the drug is safe, appropriate, or effective for you. See your health care professional for medical advice and treatment.
Product Code : 14633